Alberto Delgado‐Iribarren

2.7k total citations
50 papers, 916 citations indexed

About

Alberto Delgado‐Iribarren is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Alberto Delgado‐Iribarren has authored 50 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 18 papers in Epidemiology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Alberto Delgado‐Iribarren's work include SARS-CoV-2 and COVID-19 Research (10 papers), Antibiotic Resistance in Bacteria (10 papers) and SARS-CoV-2 detection and testing (7 papers). Alberto Delgado‐Iribarren is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Antibiotic Resistance in Bacteria (10 papers) and SARS-CoV-2 detection and testing (7 papers). Alberto Delgado‐Iribarren collaborates with scholars based in Spain, Sweden and Pakistan. Alberto Delgado‐Iribarren's co-authors include Fernando Baquero, Jesús Oteo, Marı́a Pérez-Vázquez, Verónica Bautista, Emilia Cercenado, Silvia García-Cobos, José Campos, María Velasco, Beatriz Orden and José Luis Martínez and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Emerging infectious diseases.

In The Last Decade

Alberto Delgado‐Iribarren

46 papers receiving 892 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alberto Delgado‐Iribarren Spain 14 465 252 224 202 133 50 916
Nicholas Spanakis Greece 20 569 1.2× 251 1.0× 296 1.3× 163 0.8× 153 1.2× 31 1.0k
Mesut Yılmaz Türkiye 18 531 1.1× 241 1.0× 318 1.4× 144 0.7× 174 1.3× 74 1.2k
Didier Tandé France 15 427 0.9× 230 0.9× 217 1.0× 123 0.6× 96 0.7× 27 893
E. Platsouka Greece 16 475 1.0× 204 0.8× 256 1.1× 135 0.7× 184 1.4× 33 906
Martin Sundqvist Sweden 18 468 1.0× 151 0.6× 377 1.7× 251 1.2× 114 0.9× 55 1.2k
Ya‐Sung Yang Taiwan 22 569 1.2× 275 1.1× 433 1.9× 253 1.3× 152 1.1× 84 1.2k
Chang-Pan Liu Taiwan 21 483 1.0× 303 1.2× 458 2.0× 335 1.7× 144 1.1× 58 1.3k
Assia Ben Hassen Tunisia 15 346 0.7× 174 0.7× 156 0.7× 175 0.9× 72 0.5× 49 847
Adam G. Stewart Australia 16 315 0.7× 147 0.6× 232 1.0× 202 1.0× 162 1.2× 77 868
Angella Charnot‐Katsikas United States 15 428 0.9× 210 0.8× 228 1.0× 242 1.2× 114 0.9× 30 940

Countries citing papers authored by Alberto Delgado‐Iribarren

Since Specialization
Citations

This map shows the geographic impact of Alberto Delgado‐Iribarren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Delgado‐Iribarren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Delgado‐Iribarren more than expected).

Fields of papers citing papers by Alberto Delgado‐Iribarren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Delgado‐Iribarren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Delgado‐Iribarren. The network helps show where Alberto Delgado‐Iribarren may publish in the future.

Co-authorship network of co-authors of Alberto Delgado‐Iribarren

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Delgado‐Iribarren. A scholar is included among the top collaborators of Alberto Delgado‐Iribarren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Delgado‐Iribarren. Alberto Delgado‐Iribarren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ayerdi, Oskar, et al.. (2024). Incidence of sexually transmitted infections and screening models among pre-exposure prophylaxis users. Enfermedades infecciosas y microbiologia clinica (English ed ). 42(10). 570–576.
2.
Berzosa, Arantxa, Marta Illán Ramos, David M. Arana, et al.. (2022). A Prospective Study of the Serological, Clinical, and Epidemiological Features of a SARS-CoV-2 Positive Pediatric Cohort. Children. 9(5). 665–665. 2 indexed citations
3.
Bühler, Kora‐Mareen, Víctor Echeverry‐Alzate, Javier Calleja‐Conde, et al.. (2022). Seroprevalence of anti-SARS-CoV-2 IgG antibodies: relationship with COVID-19 diagnosis, symptoms, smoking, and method of transmission. IJID Regions. 4. 10–16. 2 indexed citations
4.
Culebras, Esther, et al.. (2022). Evaluation of two immunocromatographic tests for the detection of antibodies against SARS-CoV-2. Revista Española de Quimioterapia. 36(6). 621–624. 1 indexed citations
5.
Culebras, Esther, et al.. (2021). Usefulness of SARS‐CoV‐2 antigen test sample as input for SARS‐CoV‐2 RT‐PCR analysis. Journal of Medical Virology. 94(4). 1693–1695. 4 indexed citations
6.
Amador, Paloma Merino, Fernando González‐Romo, Alberto Delgado‐Iribarren, et al.. (2021). Clinitest rapid COVID-19 antigen test for the diagnosis of SARS-CoV-2 infection: A multicenter evaluation study. Journal of Clinical Virology. 143. 104961–104961. 10 indexed citations
7.
Delgado‐Iribarren, Alberto, et al.. (2021). Comparative study of different SARS-CoV-2 diagnostic techniques. Journal of Virological Methods. 298. 114281–114281. 2 indexed citations
8.
Culebras, Esther, et al.. (2021). Usefulness of MALDI-TOF and REP-PCR against PFGE for the epidemiological study of Acinetobacter baumannii. Revista Española de Quimioterapia. 34(3). 207–213. 4 indexed citations
9.
Delgado‐Iribarren, Alberto, et al.. (2020). Evaluation of compliance with the antibiotic prophylaxis protocol in hysterectomy. Prospective cohort study. Revista Española de Quimioterapia. 33(3). 180–186. 2 indexed citations
10.
Fernández‐Rodríguez, Conrado, et al.. (2019). The contribution of telemedicine to hepatitis C elimination in a correctional facility. Revista Española de Enfermedades Digestivas. 111(7). 550–555. 26 indexed citations
11.
Colás‐Ruiz, Enrique, et al.. (2017). Evaluación de la adecuación de la profilaxis antibiótica en la cirugía de recto. Revista española de quimioterapia. Suplemento. 30(1). 14–18. 4 indexed citations
12.
Tabasco, Raquel, María Velasco, Alberto Delgado‐Iribarren, et al.. (2012). Effects on intestinal microbiota of probiotic fermented milk used for prevention of antibiotic-associated diarrhoea. European Food Research and Technology. 235(6). 1199–1206. 3 indexed citations
13.
Oteo, Jesús, Julio Hernández, Mateu Espasa, et al.. (2012). Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain. Journal of Antimicrobial Chemotherapy. 68(2). 317–321. 104 indexed citations
14.
Velasco, María, et al.. (2010). Adecuación del tratamiento empírico de la infección urinaria en urgencias. Revista Clínica Española. 210(1). 11–16. 7 indexed citations
15.
Ruiz‐Giardín, José Manuel, et al.. (2010). Modelo clínico predictivo y validación de bacteriemias por anaerobios (incluidas las bacteriemias polimicrobianas). Enfermedades Infecciosas y Microbiología Clínica. 28(7). 421–429. 5 indexed citations
16.
Velasco, María, et al.. (2009). Factores predictores de infección urinaria bacteriémica por Escherichia coli productor de betalactamasas de espectro extendido. Medicina Clínica. 134(9). 392–395. 3 indexed citations
17.
Oteo, Jesús, Alberto Delgado‐Iribarren, Verónica Bautista, et al.. (2008). Emergence of imipenem resistance in clinical Escherichia coli during therapy. International Journal of Antimicrobial Agents. 32(6). 534–537. 90 indexed citations
18.
19.
Losa, Juan Emilio, Raquel Barba, & Alberto Delgado‐Iribarren. (2002). Staphylococcus aureus resistente a meticilina. Medicina Clínica. 119(19). 755–756. 3 indexed citations
20.
Delgado‐Iribarren, Alberto, et al.. (2000). [Intravenous drug users serologic control: what may be prevented?].. PubMed. 18(1). 2–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas Spanakis Breakdown of academic impact, for papers by Mesut Yılmaz Breakdown of academic impact, for papers by Didier Tandé Breakdown of academic impact, for papers by E. Platsouka Breakdown of academic impact, for papers by Martin Sundqvist Breakdown of academic impact, for papers by Ya‐Sung Yang Breakdown of academic impact, for papers by Chang-Pan Liu Breakdown of academic impact, for papers by Assia Ben Hassen Breakdown of academic impact, for papers by Adam G. Stewart Breakdown of academic impact, for papers by Angella Charnot‐Katsikas
Rankless by CCL
2026